Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Marta G. Fuster"'
Publikováno v:
Pharmaceutics, Vol 15, Iss 4, p 1186 (2023)
The anticancer drug ibrutinib (IB), also known as PCI-32765, is a compound that irreversibly inhibits Bruton’s tyrosine kinase (BTK) and was initially developed as a treatment option for B-cell lineage neoplasms. Its action is not limited to B-cell
Externí odkaz:
https://doaj.org/article/facc3831006340398365ea6db56ace9e
Autor:
Marta G. Fuster, Imane Moulefera, Mercedes G. Montalbán, José Pérez, Gloria Víllora, Gabriel García
Publikováno v:
Molecules, Vol 27, Iss 21, p 7264 (2022)
When the [Ru(p-cymene)(μ-Cl)Cl]2 complex is made to react, in dichloromethane, with the following ligands: 2-aminobenzonitrile (2abn), 4-aminobenzonitrile (4abn), 2-aminopyridine (2ampy) and 4-aminopyridine (4ampy), after addition of hexane, the fol
Externí odkaz:
https://doaj.org/article/0d254fa76a084c9abfe0273103ea32b7
Autor:
María Angeles Pujante-Galián, Sergio A. Pérez, Mercedes G. Montalbán, Guzmán Carissimi, Marta G. Fuster, Gloria Víllora, Gabriel García
Publikováno v:
Molecules, Vol 25, Iss 21, p 5063 (2020)
In this work, the cytotoxic behavior of six ruthenium(II) complexes of stoichiometry [(η6-p-cymene)RuCl2L] (I-VI), L = 4-cyanopyridine (I), 2-aminophenol (II), 4-aminophenol (III), pyridazine (IV), and [(η6-p-cymene)RuClL2]PF6; L = cyanopyridine (V
Externí odkaz:
https://doaj.org/article/46b5cdce46c14b0db7fc65ffe829250f
Publikováno v:
Nanomaterials, Vol 10, Iss 4, p 718 (2020)
Naringenin (NAR), a flavonoid present in a variety of fruits, vegetables and herbs, exhibits a wide range of pharmacological effects, including anticancer activity. Nevertheless, its application in cancer therapy is limited due to its low bioavailabi
Externí odkaz:
https://doaj.org/article/c7758fea944f4e629d50ab95638294ae
Autor:
María Alejandra Asensio Ruiz, Marta G. Fuster, Teresa Martínez Martínez, Mercedes G. Montalbán, José Luis Cenis, Gloria Víllora, Antonio Abel Lozano-Pérez
Publikováno v:
Polymers; Volume 14; Issue 3; Pages: 498
Polymers, Vol 14, Iss 498, p 498 (2022)
Polymers, Vol 14, Iss 498, p 498 (2022)
In recent years, silk fibroin nanoparticles (SFNs) have been consolidated as drug delivery systems (DDSs) with multiple applications in personalized medicine. The design of a simple, inexpensive, and scalable preparation method is an objective pursue
Autor:
Mohamed Chaala, Fatima Zohra Sebba, Marta G. Fuster, Imane Moulefera, Mercedes G. Montalbán, Guzmán Carissimi, Gloria Víllora
Publikováno v:
Polymers; Volume 15; Issue 3; Pages: 504
The development of new biomaterials from natural fibres in the field of biomedicine have attracted great interest in recent years. One of the most studied fibres has been silk fibroin produced by the Bombyx mori worm, due to its excellent mechanical
Publikováno v:
Polymers; Volume 15; Issue 2; Pages: 382
A method for the synthesis of cellulose nanoparticles using the ionic liquid 1-ethyl-3-methylimidazolium acetate has been optimised. The use of a highly biocompatible biopolymer such as cellulose, together with the use of an ionic liquid, makes this
Publikováno v:
21st Century Nanostructured Materials-Physics, Chemistry, Classification, and Emerging Applications in Industry, Biomedicine, and Agriculture
The use of nanoparticles in biomedical fields is a very promising scientific area and has aroused the interest of researchers in the search for new biodegradable, biocompatible and non-toxic materials. This chapter is based on the features of the bio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ba8996541227e617cb7c2695fadb167c
https://mts.intechopen.com/articles/show/title/silk-fibroin-nanoparticles-synthesis-and-applications-as-drug-nanocarriers
https://mts.intechopen.com/articles/show/title/silk-fibroin-nanoparticles-synthesis-and-applications-as-drug-nanocarriers
This chapter presents a review on the design of nanoparticles which have been proposed as drug delivery systems in biomedicine. It will begin with a brief historical review of nanotechnology including the most common types of nanoparticles (metal nan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ebcb3076540b930964095ee286792c52
https://mts.intechopen.com/articles/show/title/nanoparticles-as-drug-delivery-systems
https://mts.intechopen.com/articles/show/title/nanoparticles-as-drug-delivery-systems
Autor:
Marta G. Fuster, Gloria Víllora, Mercedes G. Montalbán, J J López-Cascales, Juan J. Giner-Casares, María Gloria Villora Cano, Guzmán Carissimi, Gabriela Egly Feresin, Ricardo D. Enriz, Beatriz Lima
Publikováno v:
Nanomaterials
Volume 10
Issue 12
Nanomaterials 10(12), 2340 (2020)
Helvia: Repositorio Institucional de la Universidad de Córdoba
Universidad de Córdoba
Helvia. Repositorio Institucional de la Universidad de Córdoba
Universidad de Cantabria (UC)
CONICET Digital (CONICET)
Consejo Nacional de Investigaciones Científicas y Técnicas
instacron:CONICET
Nanomaterials, Vol 10, Iss 2340, p 2340 (2020)
Volume 10
Issue 12
Nanomaterials 10(12), 2340 (2020)
Helvia: Repositorio Institucional de la Universidad de Córdoba
Universidad de Córdoba
Helvia. Repositorio Institucional de la Universidad de Córdoba
Universidad de Cantabria (UC)
CONICET Digital (CONICET)
Consejo Nacional de Investigaciones Científicas y Técnicas
instacron:CONICET
Nanomaterials, Vol 10, Iss 2340, p 2340 (2020)
Pathogenic bacteria have the ability to develop antibiotic resistance mechanisms. Their action consists mainly in the production of bacterial enzymes that inactivate antibiotics or the appearance of modifications that prevent the arrival of the drug